Literature DB >> 23404264

Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure.

Z-H Tang1, Z Fang, F Zeng, Z Li, L Zhou.   

Abstract

BACKGROUND: We aimed to assess the extent to which metabolic syndrome (MetS) and serum uric acid (UA) and its interaction impact on diastolic heart failure (DHF).
MATERIALS AND METHODS: A total of 133 patients with DHF and 118 age- and gender-matched control subjects were studied. Echocardiography was used to assess left ventricular (LV) diastolic function. MetS was defined by suggestions of international diabetes federation (IDF, 2005). The association between MetS or UA and DHF was assessed by multivariate logistic regression analysis (MLR) controlling confounders. The interaction between MetS and UA on DHF was assessed by generalized linear model (GLM) and MLR analysis.
RESULTS: MetS and UA were independent predictors of DHF after adjustment for all variables (OR=0.833~2.27, ORUA=1.003 and p<0.05 for all). There was an interaction effect of MetS and UA on DHF (ORInt=2.41~2.66, pInt<0.05).
CONCLUSION: The findings of the present study suggested that MetS or UA is associated with DHF, and that MetS interacts with UA to impact on DHF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404264     DOI: 10.3275/8851

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.

Authors:  Kazuko Masuo; Hideki Kawaguchi; Hiroshi Mikami; Toshio Ogihara; Michael L Tuck
Journal:  Hypertension       Date:  2003-09-02       Impact factor: 10.190

Review 3.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

4.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

5.  The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.

Authors:  Horacio E Cingolani; Juan A Plastino; Eduardo M Escudero; Brian Mangal; Joanne Brown; Néstor G Pérez
Journal:  J Card Fail       Date:  2006-09       Impact factor: 5.712

Review 6.  Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

Authors:  Jesse Dawson; Matthew Walters
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

7.  Hyperuricemia in acute heart failure. More than a simple spectator?

Authors:  Anna L Alimonda; Julio Núñez; Eduardo Núñez; Oliver Husser; Juan Sanchis; Vicent Bodí; Gema Miñana; Rocio Robles; Luis Mainar; Pilar Merlos; Helene Darmofal; Angel Llácer
Journal:  Eur J Intern Med       Date:  2008-06-10       Impact factor: 4.487

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

9.  Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging.

Authors:  Linda R Peterson; Alan D Waggoner; Kenneth B Schechtman; Timothy Meyer; Robert J Gropler; Benico Barzilai; Víctor G Dávila-Román
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

Review 10.  Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy.

Authors:  D M Ouwens; M Diamant
Journal:  Arch Physiol Biochem       Date:  2007-04       Impact factor: 4.076

View more
  6 in total

1.  Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study.

Authors:  Arrigo Francesco Giuseppe Cicero; Martina Rosticci; Angelo Parini; Cristina Baronio; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2013-11-09       Impact factor: 3.397

2.  The association and interaction analysis of hypertension and diabetes mellitus on diastolic heart failure in a high-risk population.

Authors:  Xiang-Ying Meng; Yong Zhou; Jin Zhang; Zi-Hui Tang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Serum uric acid is associated with incidence of heart failure with preserved ejection fraction and cardiovascular events in patients with arterial hypertension.

Authors:  Jun Gu; Yu-Qi Fan; Hui-Li Zhang; Jun-Feng Zhang; Chang-Qian Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-15       Impact factor: 3.738

4.  Association between Low-Grade Inflammation and Left Ventricular Diastolic Dysfunction in Patients with Metabolic Syndrome and Hyperuricemia.

Authors:  Cheng-Wei Liu; Jui-Hung Chen; Guo-Shiang Tseng; Ko-Hung Chen; Juey-Jen Hwang; Wei-Shiung Yang; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

5.  Association and predictive value analysis for metabolic syndrome on systolic and diastolic heart failure in high-risk patients.

Authors:  Zi-Hui Tang; Lin Wang; Fangfang Zeng; Keqin Zhang
Journal:  BMC Cardiovasc Disord       Date:  2014-09-24       Impact factor: 2.298

6.  Association and interaction analysis of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han population.

Authors:  Hui-Hui Wu; Nai-Jia Liu; Zhen Yang; Xiao-Ming Tao; Yan-Ping Du; Xuan-Chun Wang; Bin Lu; Zhao-Yun Zhang; Ren-Ming Hu; Jie Wen
Journal:  Diabetol Metab Syndr       Date:  2014-10-01       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.